Submission Details
| 510(k) Number | K181446 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 01, 2018 |
| Decision Date | July 08, 2019 |
| Days to Decision | 402 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K181446 is an FDA 510(k) clearance for the Bard Power-Injectable Implantable Ports (PowerPorts?), a Port & Catheter, Implanted, Subcutaneous, Intravascular (Class II — Special Controls, product code LJT), submitted by C.R. Bard, Inc. (Salt Lake Ciy,, US). The FDA issued a Cleared decision on July 8, 2019, 402 days after receiving the submission on June 1, 2018. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5965.
| 510(k) Number | K181446 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 01, 2018 |
| Decision Date | July 08, 2019 |
| Days to Decision | 402 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | LJT — Port & Catheter, Implanted, Subcutaneous, Intravascular |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5965 |